Effects of blockage of urine and/or bile flow on diflunisal conjugation and disposition in rats

References

• Dickinson R. G., King A. R. Absence of diflunisal phenolic glucuronide formation in the homozygous Gunn rat. Clinical and Experimental Pharmacology and Physiology 1988; Suppl. 12: 147
   Google Scholar
• Dickinson R. G., King A. R. Reactivity considerations in the analysis of glucuronide and sulfate conjugates of diflunisal. Therapeutic Drug Monitoring 1989; 11: 712–720
   PubMed Web of Science ®Google Scholar
• Dickinson R. G., Harland R. C., Ilias A. M., Rodgers R. M., Kaufman S. N., Lynn R. K., Gerber N. Disposition of valproic acid in the rat: dose-dependent metabolism, distribution, enterohepatic recirculation and choleretic effect. Journal of Pharmacology and Experimental Therapeutics 1979; 211: 583–595
   PubMed Web of Science ®Google Scholar
• Dickinson R. G., Kluck R. M., Wood B. T., Eadie M. J., Hooper W. D. Impaired biliary elimination of β-glucuronidase-resistant ‘glucuronides’ of valproic acid after intravenous administration in the rat. Evidence for oxidative metabolism of the resistant isomers. Drug Metabolism and Disposition 1986; 14: 255–262
   PubMed Web of Science ®Google Scholar
• Dickinson R. G., King A. R., Verbeeck R. K. Elimination of diflunisal as its acyl glucuronide, phenolic glucuronide and sulphate conjugates in bile-exteriorized and intact rats. Clinical and Experimental Pharmacology and Physiology 1989; 16: 913–924
   PubMed Web of Science ®Google Scholar
• Eriksson L.-O., Wahlin-Boll E., Odar-Cederlof I., Lindholm L., Melander A. Influence of renal failure, rheumatoid arthritis and old age on the pharmacokinetics of diflunisal. European Journal of Clinical Pharmacology 1989; 36: 165–174
   PubMed Web of Science ®Google Scholar
• Faed E. M. Decreased clearance of diflunisal in renal insufficiency—an alternative explanation. British Journal of Clinical Pharmacology 1980; 10: 185–186
   PubMed Web of Science ®Google Scholar
• Faed E. M. Properties of acyl glucuronides: Implications for studies of the pharmacokinetics and metabolism of acidic drugs. Drug Metabolism Reviews 1984; 15: 1213–1249
   PubMed Web of Science ®Google Scholar
• Faed E. M., Dobbs B. R., Lee. Glucuronidation and elimination of diflunisal in the isolated perfused rat liver: effect of pretreatment with phenobarbitone, clofibric acid and spironolactone. Archives Internationales de Pharmacodynamie et de Therapie 1984; 272: 4–16
   PubMedGoogle Scholar
• Hansen-Moller J., Cornett C., Dalgaard L., Hansen S. H. Isolation and identification of the rearrangement products of diflunisal 1-O-acyl glucuronide. Journal of Pharmaceutical and Biomedical Analysis 1988; 6: 229–240
   PubMed Web of Science ®Google Scholar
• Hirom P. C., Millburn P., Smith R. L., Williams R. T. Molecular weight and chemical structure as factors in the biliary excretion of sulphonamides in the rat. Xenobiotica 1972; 2: 205–214
   PubMed Web of Science ®Google Scholar
• Hirom P. C., Millburn P., Smith R. L. Bile and urine as complementary pathways for the excretion of foreign organic compounds. Xenobiotica 1976; 6: 55–64
   PubMed Web of Science ®Google Scholar
• Klaassen C. D., Watkins J. B. Mechanisms of bile formation, hepatic uptake, and biliary excretion. Pharmacological Reviews 1984; 36: 1–67
   PubMed Web of Science ®Google Scholar
• Levy G. Decreased body clearance of diflunisal in renal insufficiency-an alternative explanation. British Journal of Clinical Pharmacology 1979; 8: 601
   PubMed Web of Science ®Google Scholar
• Lin J. H., Yeh K. C., Duggan D. E. Effect of enterohepatic circulation on the pharmacokinetics of diflunisal in rats. Drug Metabolism and Disposition 1985; 13: 321–326
   PubMed Web of Science ®Google Scholar
• Lin J. H., Hooke K. F., Yeh K. C., Duggan D. E. Dose-dependent pharmacokinetics of diflunisal in rats: dual effects of protein binding and metabolism. Journal of Pharmacology and Experimental Therapeutics 1985; 235: 402–406
   PubMed Web of Science ®Google Scholar
• Lin J. H., Ulm E. H., Duggan D. E. Possible mechanisms for reduced plasma clearance of diflunisal in rat experimental renal failure. Journal of Pharmacology and Experimental Therapeutics 1986; 238: 978–984
   PubMed Web of Science ®Google Scholar
• Lin J. H., Chen I.-W., Ulm E. H., Duggan D. E. Differential effects of phenobarbital on ester and ether glucuronidation of diflunisal in rats. Journal of Pharmacology and Experimental Therapeutics 1987; 242: 1013–1018
   PubMed Web of Science ®Google Scholar
• Loewen G. R., McKay G., Verbeeck R. K. Isolation and identification of a new major metabolite of diflunisal in man. The sulfate conjugate. Drug Metabolism and Disposition 1986; 14: 127–131
   PubMed Web of Science ®Google Scholar
• Loewen G. R., Herman R. J., Ross S. G., Verbeeck R. K. Effect of dose on the glucuronidation and sulphation kinetics of diflunisal in man: single dose studies. British Journal of Clinical Pharmacology 1988; 26: 31–39
   PubMed Web of Science ®Google Scholar
• Meffin P. J., Zilm D. M., Veenendaal J. R. Reduced clofibric acid clearance in renal dysfunction is due to a futile cycle. Journal of Pharmacology and Experimental Therapeutics 1983; 227: 732–738
   PubMed Web of Science ®Google Scholar
• Muirhead M. R., Somogyi A. A., Lloyd C., Bochner F. Deconjugation of p-hydroxytriamterene sulphate in the rat. Xenobiotica 1989; 19: 655–660
   PubMed Web of Science ®Google Scholar
• Musson D. G., Lin J. H., Lyon K. A., Tocco D. J., Yeh K. C. Assay methodology for quantification of the ester and ether glucuronide conjugates of diflunisal in human urine. Journal of Chromatography 1985; 337: 363–378
   PubMed Web of Science ®Google Scholar
• Rowe B. J., Meffin P. J. Diisopropylfluorophosphats increases clofibric acid clearance: supporting evidence for a futile cycle. Journal of Pharmacology and Experimental Therapeutics 1984; 230: 237–241
   PubMed Web of Science ®Google Scholar
• Tocco D. J., Breault G. O., Zacchei A. G., Steelman S. L., Perrier C. V. Physiological disposition and metabolism of 5-(2′,4′-difluorophenyl)salicylic acid, a new salicylate. Drug Metabolism and Disposition 1975; 3: 453–466
   PubMed Web of Science ®Google Scholar
• Verbeeck R. K., Tjandramaga T. B., Mullie A., Verbesselt R., Verberckmoes R., De Schepper P. J. Biotransformation of diflunisal and renal excretion of its glucuronides in renal insufficiency. British Journal of Clinical Pharmacology 1979; 7: 273–282
   PubMed Web of Science ®Google Scholar
• Verbeeck R. K., Dickinson R. G., Pond S. M. Biliary excretion of diflunisal conjugates in patients with T-tube drainage. European Journal of Clinical Pharmacology 1988; 34: 423–426
   PubMed Web of Science ®Google Scholar
• Wahlin-Boll E., Brantmark B., Hanson A., Melander A., Nilsson C. High-pressure liquid chromatographic determination of acetylsalicylic acid, salicylic acid, diflunisal, indomethacin, indoprofen and indobufen. European Journal of Clinical Pharmacology 1981; 20: 375–378
   PubMed Web of Science ®Google Scholar
• Watt J. A., Dickinson R. G. Reactivity of diflunisal acyl glucuronide in human and rat plasma and albumin solutions. Biochemical Pharmacology 1990; 39: 1067–1075
   PubMed Web of Science ®Google Scholar
• Watt J. A., Dickinson R. G. The effect of diethyl ether, pentobarbitone and urethane anaesthesia on difluatisal conjugation and disposition in rats. Xenobiotica 1990; 20: 289–301
   PubMed Web of Science ®Google Scholar